Cargando…
Utility of Atherosclerosis Imaging in the Evaluation of High-Density Lipoprotein–Raising Therapies
Decreased level of high density-lipoprotein cholesterol (HDL-C) is a rigorous predictor for future cardiovascular events. Much effort is being made to develop HDL-C–raising pharmacotherapies in the attempt to avert the pandemic of atherosclerotic disease. Important properties by which HDL-C–raising...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085734/ https://www.ncbi.nlm.nih.gov/pubmed/21465111 http://dx.doi.org/10.1007/s11883-011-0176-1 |